Oxford PharmaGenesis has recently held a fundraising event in Oxford and London, for Purple Day, an international initiative to increase awareness about epilepsy. To mark the day, staff wore purple to show their support for people living with this condition.

Oxford PharmaGenesis has recently joined OBN, the UK membership organization for innovative life science R&D companies in the golden triangle of Oxford, Cambridge and London – and beyond. Chris Winchester, Managing Director of Oxford PharmaGenesis, comments, “We are proud to be part of a support network for emerging life-science companies and offer our communications expertise.”

Real-world evidence (RWE) study publications and clinical trial data disclosure were two major topics of discussion at the 14th Annual Meeting of The International Publication Planning Association (TIPPA), with both keynote sessions being led by Oxford PharmaGenesis. The meeting, held in San Diego on 9–10 February 2015, was attended by an approximately even mix of…

Did you know that 1 in 10 people in the USA are living with a rare disease? To put it in perspective, that’s approximately the same as the number of people who are left-handed! Rare diseases don’t discriminate – they affect all races and religions, rich and poor, young and old. They are often chronic…

Our company Chairman and founder, Graham Shelton, is taking up a different challenge next month by taking part in The Rotary Club of Oxford North Charity Rowathon. This will involve rowing the distance of the Oxford and Cambridge Boat Race for the charity SSNAP, which supports sick and premature babies and their families.

A consensus article co-authored by researchers from the European Society for Primary Care Gastroenterology and Oxford PharmaGenesis is in the top 10 most accessed papers in a leading gastroenterology journal. The systematic-review-based consensus article breaks new ground by summarizing complex information for clinicians in primary care regarding the use of probiotics in the treatment of…